enlightenbio  Blog

GRAIL Announces $390 Million Series D Financing

MENLO PARK, Calif., May 6, 2020 – GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced a $390 million Series D financing round. New investors including Public...read more

Industry News

Find here a listing of the latest industry news in genomics, genetics, precision medicine, and beyond. Updates are provided on a monthly basis. Sign-Up for our newsletter and never miss out on the latest news...read more

Follow Me

%d bloggers like this: